Literature DB >> 35596048

Comparing the attitudes of physicians and non-physicians toward communicating a patient's BRCA1 mutation to a first-degree relative against a patient's wishes.

Jane E Zebrack1, Wei Yang2, Matthew Milone3, Max J Coppes4,5.   

Abstract

Although genetic testing can be vastly informative, it creates a dilemma if a patient does not want to disclose an abnormal genetic test to at-risk relatives. A sample of 200 participants from Nevada (100 physicians, 100 non-physicians) completed an 11-item questionnaire asking demographic information, familiarity with genetics and genetic testing, and opinions about a physician's role in a hypothetical case in which a patient does not wish to communicate her BRCA1 mutation to her sister. Although most respondents did not think the physician should notify the sister against the patient's wishes, more non-physicians (40%) than physicians (23%) contended that the physician should do so (p = 0.0119). Most respondents from both groups agreed that the physician should not have the legal duty to notify the sister, would not be morally justified in sharing genetic test results with the sister, but should have the right to notify a patient's relatives if the disease is "serious, preventable, and treatable." More non-physicians than physicians agreed that physicians should have an educational requirement on how to communicate genetic test results to patients and their family (88% vs 65%, p = 0.0002). Most physicians (70%) reported a familiarity/strong familiarity with genetic testing compared to non-physicians (33%; p < 0.0001). Future qualitative research should assess physicians' understanding of issues surrounding familial communication of genetic test results. Educational interventions to facilitate effective communication to patients and families are needed and welcomed by most physicians. Discrepancies between the attitudes of physicians and patients or the public need to be better understood and addressed.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  BRCA; Family communication; Genetic testing; HIPAA; Patient confidentiality

Year:  2022        PMID: 35596048      PMCID: PMC9314507          DOI: 10.1007/s12687-022-00591-2

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  25 in total

Review 1.  Genetic information: a joint account?

Authors:  Michael Parker; Anneke M Lucassen
Journal:  BMJ       Date:  2004-07-17

2.  Duty to warn at-risk family members of genetic disease.

Authors:  Anne-Marie Laberge; Wylie Burke
Journal:  Virtual Mentor       Date:  2009-09-01

3.  A Physician's Duty to Warn Third Parties of Hereditary Risk.

Authors:  Kristin E Schleiter
Journal:  Virtual Mentor       Date:  2009-09-01

4.  International Policies on Sharing Genomic Research Results with Relatives: Approaches to Balancing Privacy with Access.

Authors:  Rebecca Branum; Susan M Wolf
Journal:  J Law Med Ethics       Date:  2015       Impact factor: 1.718

5.  Support Seeking or Familial Obligation: An Investigation of Motives for Disclosing Genetic Test Results.

Authors:  Marisa Greenberg; Rachel A Smith
Journal:  Health Commun       Date:  2015-10-27

6.  Approaching confidentiality at a familial level in genomic medicine: a focus group study with healthcare professionals.

Authors:  Sandi Dheensa; Angela Fenwick; Anneke Lucassen
Journal:  BMJ Open       Date:  2017-02-03       Impact factor: 2.692

Review 7.  Recent developments in genetic/genomic medicine.

Authors:  Rachel H Horton; Anneke M Lucassen
Journal:  Clin Sci (Lond)       Date:  2019-03-05       Impact factor: 6.124

8.  Communicating genetic information to family members: analysis of consent forms for diagnostic genomic sequencing.

Authors:  Amicia Phillips; Emilia Niemiec; Heidi Carmen Howard; Kalliopi Kagkelari; Pascal Borry; Danya F Vears
Journal:  Eur J Hum Genet       Date:  2020-04-27       Impact factor: 4.246

Review 9.  Reconsidering the duty to warn genetically at-risk relatives.

Authors:  Mark A Rothstein
Journal:  Genet Med       Date:  2018-02-01       Impact factor: 8.822

10.  What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing?

Authors:  Nora B Henrikson; Jennifer K Wagner; Heather Hampel; Christopher DeVore; Nirupama Shridhar; Janet L Williams; Katherine E Donohue; Iftikhar Kullo; Anya E R Prince
Journal:  J Law Biosci       Date:  2020-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.